David I. Fudman

David I. Fudman is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in Inflammatory Bowel Disease (IBD) treatment through the Division of Digestive and Liver Diseases. His clinical focus includes Crohn’s disease and ulcerative colitis management.

• Bachelor’s in biology and politics from Brandeis University
• Medical degree at UT Southwestern
• Internal medicine residency at New York-Presbyterian/Columbia University Medical Center
• Gastroenterology fellowship at Beth Israel-Deaconess/Harvard Medical School

Dr. Fudman's research primarily addresses quality improvement in IBD care, with recent publications examining biologic therapy combinations, treatment response prediction through imaging biomarkers, and healthcare access disparities. His work spans clinical outcomes, pharmacological safety, and medical procedure optimization.

Current trends in his 15 most recent articles include biologic therapy combinations for IBD remission, vaccine response comparisons in immunosuppressed patients, imaging biomarkers for treatment prediction, and care model improvements in safety-net hospitals. Collaborations with institutions like Beth Israel-Deaconess, Harvard Medical School, and Columbia University Medical Center appear frequently.

Dr. Fudman is board-certified in internal medicine and gastroenterology, and actively participates in professional organizations including the American Gastroenterological Association, American College of Gastroenterology, and Crohn's and Colitis Foundation.